The combination of new drugs, new treatments and advanced data analytics solutions creates superior opportunities for patients, making treatment more effective, more affordable and less intrusive, with a positive impact on quality of life. Distribution and drug consumption models are rapidly changing with the emergence of new business avenues around individualized medicine, combination therapies, device/drug convergence, etc. In this article, Marc Herlant of Arthur D. Little, discusses how the intelligent pharmaceutical supply chain can enable a superior patient-and-caregiver experience.